BANK VONTOBEL/CALL/NOVO NORDISK ADR B/160/0.1/21.03.25 Share Price

Warrant

DE000VD3N412

Market Closed - Börse Stuttgart 07:31:26 28/06/2024 BST
1.14 EUR -0.87% Intraday chart for BANK VONTOBEL/CALL/NOVO NORDISK ADR B/160/0.1/21.03.25
Current month+62.86%
1 month+46.15%
Date Price Change
28/06/24 1.14 -0.87%
27/06/24 1.15 -4.17%
26/06/24 1.2 +13.21%
25/06/24 1.06 +1.92%
24/06/24 1.04 +2.97%

Delayed Quote Börse Stuttgart

Last update June 28, 2024 at 07:31 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Vontobel Vontobel
WKN VD3N41
ISINDE000VD3N412
Date issued 08/04/2024
Strike 160 $
Maturity 21/03/2025 (264 Days)
Parity 10 : 1
Emission price 0.72
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.2
Lowest since issue 0.59
Spread 0.01
Spread %0.93%

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,006 DKK
Average target price
949.7 DKK
Spread / Average Target
-5.56%
Consensus